Study of Aldafermin (NGM282) in Healthy Adult Male Japanese & Non-Japanese

Updated 04/16/2024

Status Completed

Clinical Trial Summary

This is an open-label study to assess safety, tolerability, and pharmacokinetics of Aldafermin (NGM282) in healthy adult male Japanese and non-Japanese subjects

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Male

Clinical Trial Details

NCT number	NCT04828265
Study type	Interventional
Source	NGM Biopharmaceuticals, Inc
Contact
Status	Completed
Phase	Phase 1
Start date	April 13, 2021
Completion date	July 6, 2021

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04135898` - A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects	Phase 1
	Completed	`NCT02395926` - To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers	Phase 1
	Recruiting	`NCT05849311` - Phase I Trial of Envafolimab for Healthy Male Subjects	Phase 1
	Active, not recruiting	`NCT06105255` - A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553	Phase 1
	Completed	`NCT01651234` - A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers	Phase 1
	Terminated	`NCT01359618` - Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart	Phase 1
	Completed	`NCT02395913` - Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)	Phase 1
	Completed	`NCT06194500` - A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants	Phase 1
	Completed	`NCT05202912` - Food Effect Study of IDX-1197 in Healthy Subjects	Phase 1